MSB 0.92% $1.08 mesoblast limited

Cell Therapy News/Articles, page-17674

  1. 532 Posts.
    lightbulb Created with Sketch. 140
    Thanks for sharing@Wilba32

    I think it important to also reference Dr Lightner's response to Dr Cheng's letter to the editor re the important role of anti-TNF in treating refractory pCD, suggesting a contributing role of MSCs....

    From Dr Lightner's reply
    "however, by definition, the patients enrolled were refractory to anti-TNF, and their fistulas had not healed despite being on medical therapy. In fact, all patients enrolled had either failed medical therapy or were on stable medical therapy for at least 3 months before study enrollment to minimize any
    confounding with MSC healing."

    Good signs but more work to do

    DYOR

    V




    Reference:
    https://hotcopper.com.au/data/attachments/6130/6130813-fffc85b353415c0e2be642c8ba462686.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.08
Change
-0.010(0.92%)
Mkt cap ! $1.233B
Open High Low Value Volume
$1.10 $1.11 $1.05 $5.002M 4.632M

Buyers (Bids)

No. Vol. Price($)
2 5697 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 1000 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$1.09
  Change
-0.010 ( 0.10 %)
Open High Low Volume
$1.09 $1.11 $1.06 1181223
Last updated 15.59pm 14/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.